Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Biochem Biophys Res Commun ; 519(1): 81-85, 2019 10 29.
Artigo em Inglês | MEDLINE | ID: mdl-31477267

RESUMO

Lipoxygenases (LOXs) are dioxygenases that catalyze the oxygenation of polyunsaturated fatty acids to hydroperoxyl derivates. These products are precursors for different lipid mediators which are associated with pathogenesis of various diseases such as asthma, atherosclerosis and cancer. Several LOXs suffer from substrate inhibition, a potential regulatory mechanism, yet it is unclear what is the cause of this phenomenon. One such enzyme is the coral 11R-LOX which displays a significant decrease in turnover rate at arachidonic acid concentrations above 30 µM. In this report, site-directed mutagenesis and inhibition assays were employed to shed light on the mechanism of substrate inhibition in 11R-LOX. We found that introduction of a positive charge to the active site entrance with Gly188Arg substitution completely eliminates the slow-down at higher substrate concentrations. Inhibition of 11R-LOX by its catalysis product, 11(R)-hydroperoxyeicosatetraenoic acid, suggests an uncompetitive mechanism. We reason that substrate inhibition in 11R-LOX is due to additional fatty acid binding by the enzyme:substrate complex at an allosteric site situated in the very vicinity of the active site entrance.


Assuntos
Araquidonato Lipoxigenases/antagonistas & inibidores , Ácidos Araquidônicos/farmacologia , Arginina/genética , Inibidores Enzimáticos/farmacologia , Glicina/genética , Sequência de Aminoácidos , Substituição de Aminoácidos , Animais , Araquidonato Lipoxigenases/genética , Araquidonato Lipoxigenases/metabolismo , Humanos , Mutagênese Sítio-Dirigida , Alinhamento de Sequência , Especificidade por Substrato/efeitos dos fármacos
2.
Biochim Biophys Acta Mol Cell Biol Lipids ; 1862(10 Pt A): 1121-1128, 2017 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-28774821

RESUMO

Lipoxygenases (LOXs), participating in inflammatory processes and cancer, are a family of enzymes with high potential as drug targets. Various allosteric effects have been observed with different LOX isozymes (e.g. lipid/ATP binding, phosphorylation), yet there is a lot of uncertainty concerning the regulation of these enzymes. It has been recently found that a number of LOXs form dimers, extending the list of possible allosteric mechanisms with oligomerization. Coral 11R-LOX is, unlike several mammalian counterparts, a stable dimer in solution facilitating quaternary structure studies that demand high sample homogeneity. By combining previous crystallographic data of 11R-LOX with small-angle X-ray scattering and chemical cross-linking, we were able to narrow down the possible dimerization interfaces, and subsequently determined the correct assembly by site-directed mutagenesis of potential contacting residues. The region of interest is located in the vicinity of an α+ß formation in the catalytic domain, also coined the PDZ-like domain. Being situated just between the active site and the dimer interface, our results further implicate this putative subdomain in the regulation of LOXs.


Assuntos
Antozoários/enzimologia , Lipoxigenase/química , Multimerização Proteica , Animais , Domínio Catalítico , Domínios PDZ , Estrutura Quaternária de Proteína , Difração de Raios X
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA